Bonnie Anderson
Co-founder, CEO & Chair, PinkDx, Inc.
Bonnie H. Anderson cofounded and serves as Chairwoman and Chief Executive Officer of PinkDx, an early-stage diagnostics company focused on addressing unmet medical needs for women. Anderson is a veteran diagnostics industry leader with a strong track record of building successful businesses in novel markets. She cofounded Veracyte, a global diagnostics company, where she served as Chief Executive Officer from 2008 to 2021. During her tenure, Anderson raised over $1 billion in private and public funding, launched market-leading diagnostic tests that are transforming patient care in multiple disease areas, and established Veracyte’s strategic vision for offering its tests to physicians and their patients globally.
Prior to Veracyte, Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. At Beckman Coulter, she led the company’s “intrapreneurial” start-up division, focused on the emerging immuno-oncology field.
Anderson also serves on the board of Bruker Corporation. Additionally, she is past-president of the Coalition for 21st Century Medicine, representing the genomic diagnostics industry to federal and state-level policymakers and regulators, and previously served on the boards of the Biotechnology Industry Organization (BIO), Castle Biosciences and DNA Script.
Anderson has received numerous awards for her industry leadership, including: Fast Company’s “100 Most Creative People in Business”; Fierce Pharma’s “Fiercest Women in Life Sciences”; and the San Francisco Business Times’ “Bay Area Most Admired CEOs.” Anderson graduated from Indiana University of Pennsylvania with a B.S. in Medical Technology and in 2012 was honored with a “Distinguished Alumni” award followed by an honorary Doctor of Science Degree in 2023.